Company · Sweden
not in the EU Transparency RegisterThis organization files on consultations without a register number, so its record here is built from its filings alone. Register facts — staff, costs, accreditations — are not available for it.
Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Track The in PolicySpeak: request access →
Work at The Swedish Association of the Pharmaceutical Industry? so we know who speaks for it.
The Swedish Association of the Pharmaceutical Industry filed 2 positions between 5 Apr 2022 and 29 Apr 2022, across 2 of the 583 legislative files tracked here, attaching a full position paper 1 time.
The significant investment in research and development (R & D) by several actors and for many years in new technologies, vaccines, therapeutic and other products, now available to deal with COVID-19, would not have existed without the current and robust EU IP system.
Filed in Swedish · English published by the European Commission
The SPC is a very important intellectual property right for pharmaceutical companies, enabling innovation and the making available of new medicines. The positive effect of the SPC in this regard was confirmed by the Commission’s evaluation of the SPC legislation in 2020. In view of the above, Lif strongly believes that no changes should be made to the SPC itself or to related legislation (alt C2).
Filed in Swedish · English published by the European Commission
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put The Swedish Association of the Pharmaceutical Industry next to another organization. Same files, same register facts, side by side. Compare →
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers — not evidence of coordination, and we do not suggest any.
Showing 5 of 19.
Everything on this page comes from The Swedish Association of the Pharmaceutical Industry’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.